Gemifloxacin
From Wikipedia, the free encyclopedia
 |
|
|
Gemifloxacin
|
|
| Systematic (IUPAC) name | |
| 7-[(4Z)-3-(aminomethyl)- 4-methoxyimino-pyrrolidin-1-yl]- 1-cyclopropyl-6-fluoro-4-oxo- 1,8-naphthyridine-3-carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C18H20FN5O4 |
| Mol. mass | 389.381 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 60-70% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Gemifloxacin mesylate (trade name Factive®, Oscient Pharmaceuticals) is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia.
| Quinolones (J01M) | |
|---|---|
| Fluoroquinolones | Ciprofloxacin, Enoxacin, Fleroxacin, Gatifloxacin, Gemifloxacin, Grepafloxacin, Levofloxacin, Lomefloxacin, Moxifloxacin, Norfloxacin, Ofloxacin, Pefloxacin, Prulifloxacin, Rufloxacin, Sparfloxacin, Temafloxacin, Trovafloxacin, Sitafloxacin |
| Other quinolones | Cinoxacin, Flumequine, Nalidixic acid, Oxolinic acid, Pipemidic acid, Piromidic acid, Rosoxacin |
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
